ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

October 20, 1995

Minority Based CCOP RFA Generate Wide Interest; 44 Letters Of Intent Received for Eight Awards

September 1, 1989

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

Community Center Group To Consider “Clinical Standards, Medical Audit”

September 13, 1974

SBIR: A Sure Fire Way to Get Funded In A Year When Applications Scoring Over 158 Are Being Dropped

February 22, 1985

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

October 1, 1999